United States Digital Cognitive Assessment and Digital Therapeutics · Inpatient Services
Comparable size, CAGR, competitive structure, and regional split for United States Digital Cognitive Assessment and Digital Therapeutics and Inpatient Services, drawn from the same source-attributed evidence ledger that backs every Meridian Consensus preview.
Size & growth
USD nominal · 2025 base| Metric | United States Digital Cognitive Assessment and Digital Therapeutics | Inpatient Services |
|---|---|---|
| Market size · 2025 | $4537.9B | $2090.0B |
| CAGR · 2025–2036 | 5.0% | 3.4% |
| Forecast · 2036 | $7802.3B | $3005.6B |
| Industry | Healthcare |
Leading operators · top 3 each
Operator-level shareUnited States Digital Cognitive Assessment and Digital Therapeutics
- 01Biogen3.2%
- 02Akili Interactive2.2%
- 03Pear Therapeutics1.9%
Inpatient Services
- 01HCA Healthcare3.6%
- 02UnitedHealth Group (Optum Health)3.3%
- 03
Regional split
Share · USD M| Region | United States Digital Cognitive Assessment and Digital Therapeutics | Inpatient Services |
|---|---|---|
| North America | – | 42%$877.8B |
| Europe | – | 26%$543.4B |
| Asia Pacific | – |
Aligned strength / weakness / opportunity / threat ledger across all markets in one frame.
2025–2036 curves overlaid on a shared axis with confidence bands and inflection markers.
Filing density, expiry cliff timing, and concentration ratios across each market’s top assignees.
Where capital is going, by sub-segment and operator type, with probability-weighted returns.
Deep competitive comparison
Full SWOT matrices, patent landscape overlay, year-by-year forecast curves, and investment thesis side-by-side for each market.
Commission the full comparison